Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Salgado

Showing results (141-150 of 277) with videos related to

Pageof 28
Sort By:
Virchows Archiv : an International Journal of Pathology|October 16, 2025
Practical consequences of the European union-AI act for anatomic pathology laboratories a European society of pathology and European society of digital and integrative pathology commissioned expert opinion paperFrederik Deman, Sofia Palmieri, Glenn Broeckx, et al.
NPJ Breast Cancer|May 29, 2021
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancerTamar Zahavi, Mali Salmon-Divon, Roberto Salgado, et al.
Nature Communications|September 28, 2021
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancerDora Hammerl, John W M Martens, Mieke Timmermans, et al.
BMC Cancer|August 7, 2021
Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trialAlex De Caluwé, Laurence Buisseret, Philip Poortmans, et al.
JCO Precision Oncology|September 22, 2023
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide CohortTessa G Steenbruggen, Denise M Wolf, Bram Thijssen, et al.
JAMA Oncology|July 17, 2015
Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO TrialRoberto Salgado, Carsten Denkert, Christine Campbell, et al.
Genome Biology|October 2, 2014
Deciphering clonality in aneuploid breast tumors using SNP array and sequencing dataIngrid M Lönnstedt, Franco Caramia, Jason Li, et al.
Histopathology|July 14, 2024
Development of a deep-learning model tailored for HER2 detection in breast cancer to aid pathologists in interpreting HER2-low casesPierre-Antoine Bannier, Glenn Broeckx, Loïc Herpin, et al.
Nature Communications|November 29, 2024
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trialMattia Rediti, David Venet, Andrea Joaquin Garcia, et al.
Clinical Endocrinology|January 10, 2008
Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's diseaseDaniella Jesus Patrick Carminatti Romanholi, Marcio Carlos Machado, Camila Canteiro Pereira, et al.
Pageof 28

Showing results (141-150 of 277) with videos related to

Sort By:
Pageof 28
Virchows Archiv : an International Journal of Pathology|October 16, 2025
Practical consequences of the European union-AI act for anatomic pathology laboratories a European society of pathology and European society of digital and integrative pathology commissioned expert opinion paperFrederik Deman, Sofia Palmieri, Glenn Broeckx, et al.
NPJ Breast Cancer|May 29, 2021
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancerTamar Zahavi, Mali Salmon-Divon, Roberto Salgado, et al.
Nature Communications|September 28, 2021
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancerDora Hammerl, John W M Martens, Mieke Timmermans, et al.
BMC Cancer|August 7, 2021
Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trialAlex De Caluwé, Laurence Buisseret, Philip Poortmans, et al.
JCO Precision Oncology|September 22, 2023
Characterization of the Tumor Microenvironment of De Novo Oligometastatic Breast Cancer in a Nationwide CohortTessa G Steenbruggen, Denise M Wolf, Bram Thijssen, et al.
JAMA Oncology|July 17, 2015
Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO TrialRoberto Salgado, Carsten Denkert, Christine Campbell, et al.
Genome Biology|October 2, 2014
Deciphering clonality in aneuploid breast tumors using SNP array and sequencing dataIngrid M Lönnstedt, Franco Caramia, Jason Li, et al.
Histopathology|July 14, 2024
Development of a deep-learning model tailored for HER2 detection in breast cancer to aid pathologists in interpreting HER2-low casesPierre-Antoine Bannier, Glenn Broeckx, Loïc Herpin, et al.
Nature Communications|November 29, 2024
Identification of HER2-positive breast cancer molecular subtypes with potential clinical implications in the ALTTO clinical trialMattia Rediti, David Venet, Andrea Joaquin Garcia, et al.
Clinical Endocrinology|January 10, 2008
Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's diseaseDaniella Jesus Patrick Carminatti Romanholi, Marcio Carlos Machado, Camila Canteiro Pereira, et al.
Pageof 28